Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma.
Kon OM; Sihra BS; Compton CH; Leonard TB; Kay AB; Barnes NC; Lancet, 1998, vol. 352, issue 9134, p 1109, ISSN 01406736. ISBN 01406736.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef